Change search
ReferencesLink to record
Permanent link

Direct link
Efficacy and safety of the dopaminergic stabilizer Pridopidine (ACR16) in patients with Huntington's disease
Show others and affiliations
2010 (English)In: Clinical neuropharmacology, ISSN 0362-5664, E-ISSN 1537-162X, Vol. 33, no 5, 260-264 p.Article in journal (Refereed) Published
Abstract [en]

Pridopidine shows promise as a treatment for some of the symptoms of HD. In this small-scale study, the most notable effect was improvement in voluntary motor symptoms. Larger, longer-term trials are warranted.

Place, publisher, year, edition, pages
2010. Vol. 33, no 5, 260-264 p.
Keyword [en]
ACR16, dopaminergic stabilizer, Huntington's disease, pridopidine, randomized clinical trial
URN: urn:nbn:se:umu:diva-42294DOI: 10.1097/WNF.0b013e3181ebb285PubMedID: 20616707OAI: diva2:409089
Available from: 2011-04-07 Created: 2011-04-07 Last updated: 2011-04-07Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Loutfi, GhadaSvenningsson, Anders
By organisation
In the same journal
Clinical neuropharmacology

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 95 hits
ReferencesLink to record
Permanent link

Direct link